Faculty of Medicine, Fayoum University
Al Fayyum, Egypt
NCT Number: NCT06031350
This series aims at studying the peripapillary and macular vascular changes in subjects with unilateral anterior ischemic optic neuropathy via Optical Coherence Tomography Angiography (OCTA).
Looking for future studies?
Notify MeUp to 40 year
All sexes
Observational
Al Fayyum, Egypt
After approval of the local institutional ethics committee and local institutional review board, This study was conducted upon 30 patients diagnosed with acute NAION attending at Ophthalmology outpatient clinic in Fayoum University Hospitals. The participants were informed about the objectives of the study, the examination, investigations and the confidentiality of their information and their right not to participate in the study. OCT and OCTA was done for all subjects and control group with Optovue, Inc., Fremont, CA, USA. Patients were examined on presentation, after 6 weeks and lastly after 3 months. OCT was used for evaluation of Central macular thickness (CMT), nerve fiber layer thickness (NFLT) and ganglion cell complex (GCC). OCTA was done for quantitative evaluation of vessel density in the following: optic nerve head and peripapillary area, macular superficial vessel density, macular deep vessel density and foveal avascular zone. Vessel density was reported as the percentage of the total area that was occupied by blood vessels. All parameters were calculated automatically by the machine software. Poor quality scans and those with motion artifacts were excluded. Statistical analysis was performed using SPSS software (version 22; SPSS, Chicago, IL, USA). The data were presented as the mean ± SD values. P-value <0.05 was considered significant.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Optovue, Inc., Fremont, CA, USA
Time frame: 3 months (0,6,12 weeks)
comparing vessel density in different areas and sectors of diseased and fellow eyes
Time frame: 3 months (0,6,12 weeks)
comparing thickness of Central macular thickness (CMT), nerve fiber layer thickness (NFLT) and ganglion cell complex (GCC)
Omar Said
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05305079
Cranial Nerve Diseases, Eye Diseases
Palo Alto, California, United States
View Trial DetailsNCT03758118
Non-arteritic Ischemic Optic Neuropathy
Roma, Italy
View Trial DetailsNCT02045212
Cardiovascular Diseases, Cranial Nerve Diseases
Nahariya, Israel
View Trial DetailsNCT01614158
Non-arteritic Ischemic Optic Neuropathy
Tübingen, Baden-Wurttemberg, Germany
View Trial Details